Low-molecular weight heparin vs. unfractionated heparin during percutaneous coronary interventions

Abstract

Use of LMWH during PTCA in stable angina. Evaluation of number, activity and aggregation of platelets and thrombin activity.

Difference in complication occurrence after PTCA in patients treated with UFH and LMWH.